In elderly moderate AS, haemodynamic progression is common but does not predict overall mortality, which is largely driven by non-cardiovascular comorbidity, highlighting the need for holistic patient assessment when guiding management strategies.
Abstract
Moderate aortic stenosis (AS) in elderly patients is heterogeneous, and survival is often influenced by non-cardiovascular comorbidities. The prognostic significance of haemodynamic progression in this population remains unclear.
We retrospectively analysed 329 patients with newly diagnosed moderate AS (2015–2016), excluding mild AS, bicuspid valves, and significant concomitant valvular disease. A subgroup of 186 patients with long-term follow-up was stratified by progression to severe AS: rapid (≤3 years), intermediate (4–9 years), or non-progressors (≥10 years). Associations between baseline characteristics, progression, and mortality were assessed over a median follow-up of 59 months (IQR 19–105).
Mean age was 78±10 years and 53% (174/329) were male. Overall, 30% (99/329) of patients progressed to severe AS; older age and higher baseline mean gradient independently predicted progression (p<0.05). Rapid progressors had higher baseline Vmax and mean gradients despite similar aortic valve area. Overall mortality was high (79.6%) and predominantly non-cardiovascular. Patients with stable moderate AS exhibited a higher all-cause mortality rate than those who progressed to severe AS (83.5% vs. 70.7%, p = .008). (Figure 1) Similarly, a higher incidence of cardiovascular death was observed in the stable moderate group (16.5% vs. 15.2%, p = .030).
In our subgroup analysis, non-progressors had the highest mortality (89.8%) compared with rapid (72.5%) and intermediate (68.9%) progressors (p=0.007). Cardiovascular mortality was low overall (8–16%).(Figure 2)
In elderly moderate AS, haemodynamic progression is common but does not predict overall mortality, which is largely driven by non-cardiovascular comorbidity. The shorter survival among non-progressors reflects competing-risk effects, demonstrating a dissociation between disease progression and survival. These findings question the prognostic value of haemodynamic trajectory alone and emphasize the need for holistic patient assessment when guiding management strategies.Survival outcomes 1Survival outcomes 2
Aortic stenosis (AS) is the most common valvular disease requiring intervention while mitral regurgitation (MR) is the most common valvular disease. Although combined moderate disease is frequently coexisting, clinical evidence about this group prognosis is lacking.
We aimed to evaluate long-term mortality...
E. Prinz, A. Kaplan, E. Maor et al.· European Heart Journal· 0 citations
Moderate aortic regurgitation (AR) is common, but data on its natural history and progression, especially when associated with concomitant moderate valvular heart disease (VHD), are limited, and its long-term prognostic impact remains unclear.
To compare the natural history of isolated moderate AR with tha...
G. Benzoni, J. M. Monteagudo-Ruiz, A. González Gómez et al.· European Heart Journal· 0 citations
Sex-related differences are well recognized in isolated aortic stenosis (AS) and aortic regurgitation (AR). However, data on mixed aortic valve disease, particularly moderate AS with concomitant AR, remain limited.
A total of 220 consecutive patients with moderate AS and moderate AR were retrospectively en...
S. Park, Y. Kim, Lee Jy et al.· European Heart Journal· 0 citations
Some studies have shown that patients with aortic stenosis (AS) have a poor prognosis, even when the stenosis is moderate (1,2). Extravalvular staging has been shown to be a useful tool for assessing the short- and mid-term prognosis of these patients (3)
To determine the long-term prognosis of a cohort of...
G. Rodriguez, T. Sevilla, J. F. Gil-Fernández et al.· European Heart Journal· 0 citations
Severe tricuspid regurgitation (TR) is strongly associated with increased mortality, supported by robust clinical data. However, sex-related differences in the natural history and prognosis of TR remain inadequately characterized.
To evaluate sex-related differences in outcomes among patients with varying...
N. Karra, L. Segev-Steinbuch, V. Copeland et al.· European Heart Journal· 0 citations
Because mixed aortic valve disease (MAVD) has complex hemodynamic characteristics, grading its severity remains challenging. We propose a new approach for grading MAVD based on the deviation of mean pressure gradient (PG) from the expected value, which may better reflect the overall hemodynamic burden.
Bet...
S. Park, Y. K., J. Lee et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.